EUVIMEDEUVIMED entdecken
Open Access

Assessment of High-Volume Antibiotic and Opioid Prescribing by Medicare Part D Prescribers―United States, 2021

Axel A Vazquez Deida iD, Christine Kim, Katryna A Gouin, Kun Zhang, Christina A Mikosz, Melinda M Neuhauser, Sarah Kabbani

Public Health Reports® · 2026

DOI: 10.1177/00333549251384449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Reports®, 2026. Verfasst von Axel A Vazquez Deida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Medicare Part D, Analgesics, Opioid, Anti-Bacterial Agents, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Characterizing high-volume co-prescribing of antibiotics and opioids can inform interventions that improve prescribing practices. Using 2021 Medicare Part D data, we conducted a cross-sectional analysis to assess concordance between high-volume prescribing of antibiotics and opioids and characterize associations between prescriber-level factors and high-volume co-prescribing of antibiotics and opioids. High-volume antibiotic prescribers accounted for 12.5 million (36.0%) antibiotic prescriptions, and high-volume opioid prescribers accounted for 22.3 million (51.9%) opioid prescriptions. We found fair concordance between being a high-volume prescriber of antibiotics and a high-volume prescriber of opioids (κ = 0.30). Prescribers in the South (adjusted odds ratio [AOR] = 3.67; 95% CI, 3.46-3.90) and in rural areas (AOR = 2.32; 95% CI, 2.12-2.54) were more likely to be high-volume co-prescribers of antibiotics and opioids than prescribers in the West and in urban areas, respectively. Public health and professional organizations can partner to provide support to optimize antibiotic and opioid prescribing practices and improve patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicare Part DAnalgesics, OpioidAnti-Bacterial AgentsPractice Patterns, Physicians'Drug PrescriptionsHumansUnited StatesCross-Sectional StudiesMaleFemaleAged

Stichwörter der Autor:innen

antibioticsantimicrobial stewardshipopioidsprescribing behaviorprescriptions

Substanzen

Analgesics, OpioidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

ORCID-Profile: Axel A Vazquez Deida

Förderung

  • Intramural CDC HHS

Zitieren

APA

Vazquez Deida, A. A., Kim, C., Gouin, K. A., Zhang, K., Mikosz, C. A., Neuhauser, M. M., & Kabbani, S. (2026). Assessment of High-Volume Antibiotic and Opioid Prescribing by Medicare Part D Prescribers―United States, 2021. Public Health Reports®. https://doi.org/10.1177/00333549251384449

Vancouver

Vazquez Deida AA, Kim C, Gouin KA, Zhang K, Mikosz CA, Neuhauser MM, et al. Assessment of High-Volume Antibiotic and Opioid Prescribing by Medicare Part D Prescribers―United States, 2021. Public Health Reports®. 2026. doi:10.1177/00333549251384449

BibTeX
@article{VazquezDeida2026,
  author = {Vazquez Deida, Axel A and Kim, Christine and Gouin, Katryna A and Zhang, Kun and Mikosz, Christina A and Neuhauser, Melinda M and Kabbani, Sarah},
  title = {Assessment of High-Volume Antibiotic and Opioid Prescribing by Medicare Part D Prescribers―United States, 2021},
  journal = {Public Health Reports®},
  year = {2026},
  doi = {10.1177/00333549251384449}
}
Kostenlos starten →